These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
170 related items for PubMed ID: 12398872
1. Effect of mycophenolate mofetil therapy on lymphocyte activation in heart transplant recipients. Weigel G, Griesmacher A, Karimi A, Zuckermann AO, Grimm M, Mueller MM. J Heart Lung Transplant; 2002 Oct; 21(10):1074-9. PubMed ID: 12398872 [Abstract] [Full Text] [Related]
2. Effect of mycophenolate mofetil therapy on inosine monophosphate dehydrogenase induction in red blood cells of heart transplant recipients. Weigel G, Griesmacher A, Zuckermann AO, Laufer G, Mueller MM. Clin Pharmacol Ther; 2001 Mar; 69(3):137-44. PubMed ID: 11240978 [Abstract] [Full Text] [Related]
3. Effect of mycophenolate mofetil in heart transplantation. Mathieu P, Carrier M, White M, Pellerin M, Perrault L, Pelletier G, Robitaille D, Pelletier LC. Can J Surg; 2000 Jun; 43(3):202-6. PubMed ID: 10851414 [Abstract] [Full Text] [Related]
4. CD69 expression on peripheral CD4+ T cells parallels disease activity and is reduced by mycophenolate mofetil therapy in uveitis. Kilmartin DJ, Fletcher ZJ, Almeida JA, Liversidge J, Forrester JV, Dick AD. Invest Ophthalmol Vis Sci; 2001 May; 42(6):1285-92. PubMed ID: 11328741 [Abstract] [Full Text] [Related]
5. Lymphocyte activation and correlation with IMPDH activity under therapy with mycophenolate mofetil. Devyatko E, Dunkler D, Bohdjalian A, Zuckermann A, Grimm M, Muehlbacher F, Weigel G. Clin Chim Acta; 2008 Aug; 394(1-2):67-71. PubMed ID: 18474232 [Abstract] [Full Text] [Related]
6. Effects of mycophenolate mofetil on donor-specific antibody formation in renal transplantation. Lederer SR, Friedrich N, Banas B, Welser G, Albert ED, Sitter T. Clin Transplant; 2005 Apr; 19(2):168-74. PubMed ID: 15740551 [Abstract] [Full Text] [Related]
8. Ex vivo lymphocyte proliferative function is severely inhibited in renal transplant patients on mycophenolate mofetil treatment. Hutchinson P, Jose M, Atkins RC, Holdsworth SR. Transpl Immunol; 2004 Feb; 13(1):55-61. PubMed ID: 15203129 [Abstract] [Full Text] [Related]
9. Sustained suppression of peripheral blood immune functions by treatment with mycophenolate mofetil correlates with reduced severity of cardiac allograft rejection. Klupp J, van Gelder T, Dambrin C, Regieli JJ, Boeke K, Billingham ME, Morris RE. J Heart Lung Transplant; 2004 Mar; 23(3):334-51. PubMed ID: 15019644 [Abstract] [Full Text] [Related]
10. Peripheral CD4+ CD25+ Treg cell expansion in lung transplant recipients is not affected by calcineurin inhibitors. Meloni F, Morosini M, Solari N, Bini F, Vitulo P, Arbustini E, Pellegrini C, Fietta AM. Int Immunopharmacol; 2006 Dec 20; 6(13-14):2002-10. PubMed ID: 17161354 [Abstract] [Full Text] [Related]
11. Mycophenolate mofetil, an inhibitor of inosine monophosphate dehydrogenase, causes a paradoxical elevation of GTP in erythrocytes of renal transplant patients. Goldsmith D, Carrey EA, Edbury S, Smolenski RT, Jagodzinski P, Simmonds HA. Clin Sci (Lond); 2004 Jul 20; 107(1):63-8. PubMed ID: 14723604 [Abstract] [Full Text] [Related]
12. Cell cycling in HIV infection: analysis of in vivo activated lymphocytes. Mahalingam M, Pozniak A, McManus TJ, Vergani D, Peakman M. Clin Exp Immunol; 1995 Dec 20; 102(3):481-6. PubMed ID: 8536361 [Abstract] [Full Text] [Related]
13. Individualizing combination of two antiproliferative immunosuppressants with pharmacodynamic modeling of stimulated lymphocyte responses. Berry V, Magill A, Yost M, Janosky J, Sindhi R. Cytometry A; 2006 Feb 20; 69(2):95-103. PubMed ID: 16369935 [Abstract] [Full Text] [Related]
14. Tacrolimus/mycophenolate mofetil improved natural killer lymphocyte reconstitution one year after kidney transplant by reference to cyclosporine/azathioprine. Vacher-Coponat H, Brunet C, Moal V, Loundou A, Bonnet E, Lyonnet L, Ravet S, Sampol-Manos E, Sampol J, Berland Y, George FD, Paul P. Transplantation; 2006 Aug 27; 82(4):558-66. PubMed ID: 16926601 [Abstract] [Full Text] [Related]
15. Inhibition of endothelial receptor expression and of T-cell ligand activity by mycophenolate mofetil. Blaheta RA, Leckel K, Wittig B, Zenker D, Oppermann E, Harder S, Scholz M, Weber S, Schuldes H, Encke A, Markus BH. Transpl Immunol; 1998 Dec 27; 6(4):251-9. PubMed ID: 10342739 [Abstract] [Full Text] [Related]
16. Inhibition of inosine monophosphate dehydrogenase activity by the plasma of heart transplant recipients receiving mycophenolate mofetil. Griesmacher A, Weigel G, Seebacher G, Mallinger R, Laufer G, Müller MM. Adv Exp Med Biol; 1998 Dec 27; 431():537-41. PubMed ID: 9598124 [No Abstract] [Full Text] [Related]
17. Effect of mycophenolate mofetil regimen on peripheral blood lymphocyte subsets in kidney transplant recipients. Bravo Soto JA, Esteban de la Rosa RJ, Luna del Castillo JD, Cerezo Morales S, García Olivares E, Osuna Ortega A, Asensio Peinado C. Transplant Proc; 2003 Jun 27; 35(4):1355-9. PubMed ID: 12826158 [Abstract] [Full Text] [Related]
18. Comparison between mycophenolate mofetil- and azathioprine-based immunosuppressions in clinical lung transplantation. Zuckermann A, Klepetko W, Birsan T, Taghavi S, Artemiou O, Wisser W, Dekan G, Wolner E. J Heart Lung Transplant; 1999 May 27; 18(5):432-40. PubMed ID: 10363687 [Abstract] [Full Text] [Related]
19. Shigella infection induces cellular activation of T and B cells and distinct species-related changes in peripheral blood lymphocyte subsets during the course of the disease. Islam D, Bardhan PK, Lindberg AA, Christensson B. Infect Immun; 1995 Aug 27; 63(8):2941-9. PubMed ID: 7622216 [Abstract] [Full Text] [Related]
20. Effect of mycophenolate mofetil on IMP dehydrogenase after the first dose and after long-term treatment in renal transplant recipients. Glander P, Hambach P, Braun KP, Fritsche L, Waiser J, Mai I, Neumayer HH, Budde K. Int J Clin Pharmacol Ther; 2003 Oct 27; 41(10):470-6. PubMed ID: 14703953 [Abstract] [Full Text] [Related] Page: [Next] [New Search]